« Previous
Next »
Neuromuscular Disorders
Volume 20, Issue 2
, Pages 136-138
, February 2010
Myositis in Griscelli syndrome type 2 treated with hematopoietic cell transplantation
References
- Griscelli syndrome restricted to hypopigmentation results from a melanophilin defect (GS3) or a MYO5A F-exon deletion (GS1). J Clin Invest. 2003;112:450–456
- . Griscelli syndrome: a model system to study vesicular trafficking. Pigment Cell Melanoma Res. 2009;22(3):268–282
- Griscelli syndrome-type 2 in twin siblings: case report and update on RAB27A human mutations and gene structure. Braz J Med Biol Res. 2008;41(10):839–848
- . Macrophage activation syndrome. Curr Opin Rheumatol. 2002;145:48–52
- Griscelli syndrome type 2: a rare and lethal disorder. J Child Neurol. 2008;239:64–67
- Successful treatment of Griscelli syndrome with unrelated donor allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2002;29:995–998
- Partial albinism with immunodeficiency (Griscelli syndrome). J Pediatr. 1994;125:886–895
- . Autopsy findings in 27 children with haemophagocytic lymphohistiocytosis. Histopathology. 1998;32:310–316
- . Hemophagocytic syndromes. Blood Rev. 2007;212:45–53
- Human immunodeficiency virus-associated polymyositis: a longitudinal study of outcome. Arthritis Rheum. 2003;491:72–78
- . Phelps RG Griscelli syndrome. Skinmed. 2007;6:147–149
PII: S0960-8966(09)00691-9
doi: 10.1016/j.nmd.2009.11.009
© 2009 Elsevier B.V. All rights reserved.
« Previous
Next »
Neuromuscular Disorders
Volume 20, Issue 2
, Pages 136-138
, February 2010
